MedTrace Logo

A Study to Evaluate the Q Revascularization System for Neurointervention in Acute Ischemic Stroke

NCT04437862 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 121

Last updated 2024-08-09

No results posted yet for this study

Summary

Assess the safety and efficacy of the Q Revascularization System to remove thrombi and emboli from the neurovasculature in patients experiencing an acute ischemic stroke

Conditions

  • Acute Stroke
  • Cerebral Ischemia

Interventions

DEVICE

Q Revascularization System

Q Revascularization System for mechanical thrombectomy

Sponsors & Collaborators

  • MIVI Neuroscience, Inc.

    lead INDUSTRY

Principal Investigators

  • Christopher Cognard, PhD, MD · Hôpital Purpan

  • Lucas Elijovich, MD · University of Tennessee Health Sciences Center

  • Brian Jankowitz, MD · JFK University Medical Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-27
Primary Completion
2023-04-21
Completion
2023-08-02
FDA Device
Yes

Countries

  • United States
  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04437862 on ClinicalTrials.gov